GlaxoSmithKline, AmfAR Form Pact to Optimize HIV Treatment in Asia
June 21, 2010
GlaxoSmithKline and amfAR on Thursday announced a project to improve the quality and accessibility of health care for HIV-positive infants and children in Asia. The partners created the two-year, $2 million initiative to produce clinical evidence and develop strategies to support pediatric care, as well as to inform global treatment guidelines.
Wall Street Journal
06.17.2010; Ian Walker, Dow Jones Newswires
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
Add Your Comment:
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)